OMA1 Protein

📖 Wiki Page

protein1217 wordssynced 2026-04-02

OMA1 Protein (Mitochondrial Metallopeptidase)

Introduction

Oma1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>OMA1 (OMA1 Metallopeptidase)</td></tr>
<tr><th>Gene</th><td>[OMA1](/genes/oma1)</td></tr>
<tr><th>UniProt ID</th><td>[Q9Y5X4](https://www.uniprot.org/uniprot/Q9Y5X4)</td></tr>
<tr><th>NCBI Gene ID</th><td>[115208](https://www.ncbi.nlm.nih.gov/gene/115208)</td></tr>
<tr><th>Molecular Weight</th><td>51 kDa (475 amino acids)</td></tr>
<tr><th>Subcellular Localization</th><td>Mitochondrial inner membrane</td></tr>
<tr><th>Protein Family</th><td>M23 metallopeptidase family</td></tr>
<tr><th>Brain Expression</th><td>High in neurons, especially dopaminergic neurons</td></tr>
<tr><th>Associated Diseases</th><td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)</td></tr>
</table>
</div>

Overview

...

OMA1 Protein (Mitochondrial Metallopeptidase)

Introduction

Oma1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

OMA1 (Overlapping Activity with M-AAA Protease 1) is a mitochondrial inner membrane zinc metallopeptidase that plays critical roles in mitochondrial dynamics, quality control, and stress responses. Located in the inner mitochondrial membrane, OMA1 is essential for processing OPA1 (optic atrophy 1 protein), the key mediator of mitochondrial inner membrane fusion[@zhang2024]. This protease also coordinates the mitochondrial response to various stress conditions, including oxidative stress, nutrient deprivation, and mitochondrial DNA damage.

In the brain, OMA1 is particularly important for maintaining mitochondrial health in [neurons](/cell-types/neurons), especially the [dopaminergic neurons of the substantia nigra](/cell-types/substantia-nigra-pars-compacta-dopamine-neurons) that degenerate in [Parkinson's disease](/diseases/parkinsons-disease)[@head2009]. Dysregulation of OMA1 function contributes to mitochondrial dysfunction, a hallmark of numerous neurodegenerative disorders.

Structure

OMA1 is a 475-amino acid protein with a complex domain architecture:

Primary Structure

Length: 475 amino acids
Molecular weight: ~51 kDa
Isoforms: Single isoform described

Domain Organization

N-terminal region (amino acids 1-80): Contains a mitochondrial targeting sequence and transmembrane helix that anchors OMA1 to the inner mitochondrial membrane[@deshwal2020].

Proline-rich region (amino acids 81-150): Flexible linker region containing potential regulatory phosphorylation sites.

M23 metallopeptidase domain (amino acids 151-450): Catalytic domain facing the mitochondrial matrix containing the zinc-binding motif HExxH. This domain is characteristic of the M23 family of metallopeptidases[@baker2014].

C-terminal region (amino acids 451-475): Regulatory tail that may interact with other mitochondrial proteins.

Structural Features

Zinc-binding motif: H^164E^165XXH^169 coordinates zinc ion essential for catalytic activity
Dimerization interface: OMA1 can form dimers and higher-order oligomers for enhanced activity
Membrane topology: N-terminus in intermembrane space, C-terminal catalytic domain in matrix

Post-Translational Modifications

Proteolytic processing: OMA1 undergoes auto-catalytic cleavage that activates the protease
Phosphorylation: Multiple serine/threonine kinases may regulate OMA1 activity
Oxidative modification: Cysteine residues sensitive to oxidative stress

Normal Function

Mitochondrial Dynamics

OMA1 is best characterized for its role in regulating mitochondrial inner membrane fusion:

OPA1 Processing

OMA1 cleaves OPA1 at multiple sites (S1 and S2) to generate long and short OPA1 isoforms[@anand2014]
Balance between long and short OPA1 isoforms regulates mitochondrial inner membrane fusion
Under stress conditions, OMA1-mediated OPA1 cleavage promotes mitochondrial fission

Mitochondrial Quality Control

OMA1 activation occurs in response to mitochondrial stress
Coordinates with [PARL](/proteins/parl) and other proteases for mitochondrial protein quality control
Helps eliminate damaged mitochondrial components through mitophagy

Stress Response

Oxidative Stress

Mitochondrial [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) activate OMA1
OMA1-mediated OPA1 cleavage facilitates removal of damaged mitochondria
Prevents accumulation of dysfunctional mitochondria

Metabolic Stress

Nutrient deprivation activates OMA1
Coordinates metabolic adaptation through mitochondrial remodeling
Affects ATP production efficiency

Apoptosis Regulation

OMA1 activation can precede cytochrome c release
Contributes to mitochondrial outer membrane permeabilization (MOMP)
Regulates execution of intrinsic [apoptosis](/entities/apoptosis) pathway

Role in Neurodegenerative Diseases

Parkinson's Disease

OMA1 dysfunction is strongly implicated in PD pathogenesis:

Dopaminergic Neuron Vulnerability

OMA1 activity is dysregulated in [substantia nigra](/brain-regions/substantia-nigra) dopaminergic [neurons](/entities/neurons)
Impaired OPA1 processing leads to mitochondrial fragmentation
Contributes to selective vulnerability of [SNc neurons](/cell-types/substantia-nigra-pars-compacta-dopamine-neurons)

PINK1/Parkin Pathway

OMA1 interacts with [PINK1](/genes/pink1) and [PARKIN](/genes/parkin) pathways
OMA1-mediated cleavage of OPA1 facilitates mitophagy
Loss of OMA1 regulation impairs mitophagic clearance of damaged mitochondria

Mitochondrial Dysfunction

Elevated OMA1 activity in PD models leads to excessive mitochondrial fission
Loss of mitochondrial membrane potential in dopaminergic neurons
Increased susceptibility to mitochondrial toxins (MPTP, rotenone)

Alzheimer's Disease

Mitochondrial Dynamics Impairment

OMA1/OPA1 balance disrupted in [AD neurons](/cell-types/neurons)
Enhanced mitochondrial fragmentation in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)
Contributes to synaptic dysfunction and neuronal loss

[Amyloid-Beta](/proteins/amyloid-beta) Effects

Aβ oligomers alter OMA1 localization and activity
OMA1 dysregulation exacerbates mitochondrial dysfunction in AD
May contribute to early synaptic deficits

[Tau](/proteins/tau) Pathology

Hyperphosphorylated [tau](/proteins/tau) affects mitochondrial trafficking
OMA1-mediated quality control becomes impaired
Creates feed-forward cycle of mitochondrial damage

Amyotrophic Lateral Sclerosis

Mitochondrial Fragmentation

OMA1 hyperactivation in ALS motor neurons
Excessive mitochondrial fission contributes to energy deficits
Motor neurons particularly vulnerable to mitochondrial dysfunction

Protein Aggregate Clearance

OMA1 activity may be affected by [TDP-43](/proteins/tardbp-protein) pathology
Impaired mitochondrial quality control in ALS
Contributes to aggregation of misfolded proteins

Other Neurodegenerative Conditions

Huntington's Disease

Mutant [huntingtin](/proteins/huntingtin-protein) affects OMA1 localization
Mitochondrial dynamics impaired in HD
OMA1 dysregulation contributes to neuronal dysfunction

Multiple System Atrophy

Mitochondrial dysfunction in oligodendrocytes
OMA1 may contribute to MSA pathogenesis
Energy deficits in affected brain regions

Therapeutic Implications

Biomarker Potential

Blood/CSF OMA1: Could serve as mitochondrial dysfunction biomarker
Activity assays: Measure OMA1 protease activity in patient samples
Correlation studies: OMA1 levels correlate with disease progression

Therapeutic Targets

Inhibiting OMA1 Overactivity

Small molecule OMA1 inhibitors under development
Peptide-based inhibitors targeting catalytic domain
Could reduce excessive mitochondrial fission in disease

Enhancing OMA1 Function

Activators to improve mitochondrial quality control
Gene therapy approaches to increase OMA1 expression
Must balance beneficial and detrimental effects

Drug Development

Natural compounds: Some polyphenols modulate OMA1 activity
Targeted delivery: Mitochondrial-targeted OMA1 modulators
Combination therapies: OMA1 modulators with other mitochondrial protectants

Interactions and Pathways

Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| [OPA1](/genes/opa1) | Proteolytic substrate | Mitochondrial inner membrane fusion |
| PARL | Protease partner | Mitochondrial quality control |
| [PINK1](/genes/pink1) | Pathway interaction | Mitophagy regulation |
| [PARKIN](/genes/parkin) | Pathway interaction | Mitophagy initiation |
| YME1L1 | Protease complex | Mitochondrial protein quality control |

Signaling Pathways

PINK1/PARKIN mitophagy pathway: OMA1 acts downstream of PINK1
MAM (Mitochondria-Associated Membranes): OMA1 localizes to MAM domains
cAMP/PKA signaling: PKA can phosphorylate OMA1
AMPK energy sensing: AMPK activation affects OMA1 activity

Research Techniques

Detection Methods

Immunoblotting: Detect OMA1 and OPA1 cleavage products
Activity assays: Fluorogenic substrates for protease activity
Immunohistochemistry: OMA1 localization in brain tissue
Proteomics: OMA1 cleavage targets identified by mass spectrometry

Model Systems

OMA1 knockout mice: Viable but show mitochondrial dysfunction
Conditional knockout: Brain-specific OMA1 deletion models
iPSC-derived neurons: Patient-specific models for PD and AD

Genetic Studies

GWAS: OMA1 variants associated with neurodegenerative disease risk
Expression studies: OMA1 expression altered in disease brains
eQTL mapping: Regulatory variants affecting OMA1 expression

Background

The study of Oma1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

OMA1 Protein

OMA1 Protein (Mitochondrial Metallopeptidase)

Introduction

Overview

OMA1 Protein (Mitochondrial Metallopeptidase)

Introduction

Overview

Structure

Primary Structure

Domain Organization

Structural Features

Post-Translational Modifications

Normal Function

Mitochondrial Dynamics

Stress Response

Apoptosis Regulation

Role in Neurodegenerative Diseases

Parkinson's Disease

Alzheimer's Disease

Amyotrophic Lateral Sclerosis

Other Neurodegenerative Conditions

Therapeutic Implications

Biomarker Potential

Therapeutic Targets

Drug Development

Interactions and Pathways

Protein Interactions

Signaling Pathways

Research Techniques

Detection Methods

Model Systems

Genetic Studies

Background

See Also